So the presentation from 3 days ago which said they would file for FDA approval is, IMO, the single most important item for them. You know they had already typed up this 8k. They are going streamlined with only essential expenditures, of which FDA should be the only item on their list.

Once they get approval I would expect sunny days for them with the release of their test study results. The economy in Israel has tanked so no huge surprise they are in a money crunch. Makes entry into the US market in 2024 vital to IR-MED